OVERVIEW

Adoptive immunotherapy has shown encouraging results in treating select hematologic malignancies and has the promise to be applied to more diseases. In 2020, a generous gift from the Jonas family established the David and Etta Jonas Center for Cellular Therapy at UChicago Medicine. This center aims to unite a multidisciplinary team of experts to accelerate research and the clinical development of cellular therapeutics. To further this goal, this activity gathers national experts to discuss basic science and translational research advances in cellular therapy for hematologic malignancies, solid tumors, and non-oncologic conditions. It will facilitate scientific discussion, foster collaboration, and disseminate knowledge of cellular therapy to ultimately improve patients' lives.

TARGET AUDIENCE

This activity is designed for medical oncologists, oncology fellows, basic scientists, research fellows, immunologists, and other healthcare professionals interested in tumor immunology and cellular immunotherapy.

LEARNING OBJECTIVES

After this activity, participants will be able to:

• List mechanisms of relapse/resistance to cellular therapy;
• Identify current applications of CAR T-cell therapy in hematologic malignancies;
• Identify relevant targets and new therapeutic approaches for cellular therapy in solid tumor malignancies;
• Consider current strategies using cellular therapy for the treatment of non-malignant conditions;
• Describe current approaches and challenges using cellular therapy in patients with solid tumor malignancies;
• Evaluate strategies to overcome resistance to cellular therapy treatment approaches;
• Assess new therapeutic strategies in cellular therapy research.

ACCREDITATION

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.